Central Garden & Pet Company (Class A) (CENTA)

Nasdaq Consumer Staples Household Products S&P SmallCap 600
$40.80
-0.28 (-0.68%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+4.3%
1M+16.5%
3M+6.8%
6M+19.2%
YTD+39.8%
1Y+43.6%
3Y+29.3%
5Y+10.4%

Key statistics

Full financials →
Market cap$2.5B
P/E (TTM)15.1
EPS (TTM, diluted)$2.70
P/S0.82
P/B1.45
EV / EBITDA8.2
Revenue (TTM)$3.08B
Revenue growth-1.2%
Net margin5.4%
ROE9.5%
Debt / equity0.68
FCF yield13.7%
Dividend yield—
Payout ratio—
Beta (1Y)0.26
Volatility (1Y)25.5%
52-week range$27.41 – $42.44
Avg volume (50D)339.14K

Revenue & net income — last 8 quarters

Statements →
Sep 21, 9:14 PM ET

Central Garden & Pet: President of Garden Consumer Products John Walker to retire Sept. 26

Neutral leadership Written later 5.02

Central Garden & Pet said John D. Walker will retire as President, Garden Consumer Products, effective September 26, 2026. The filing does not name a successor or describe the reasons for the retirement.

  • John D. Walker is retiring as President, Garden Consumer Products.
  • The retirement is effective September 26, 2026.
  • The company announced the change on September 21, 2026.
  • The filing does not name a successor or give financial figures.
Read the filing on SEC.gov ↗
Aug 5, 4:15 PM ET

Central Garden & Pet raises fiscal 2026 EPS outlook to $2.85 or better; Q3 sales fall 8%

Mixed earnings Written later 2.02

Central Garden & Pet reported fiscal 2026 third-quarter net sales of $882 million, down 8% from $961 million, while organic net sales rose 2%. The company raised its fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better from $2.70 or better, and agreed after quarter-end to acquire an 80% interest in TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments.

  • Q3 net sales were $882 million versus $961 million, down 8%; organic net sales rose 2% to $862 million versus $842 million.
  • Q3 GAAP diluted EPS was $1.45 versus $1.52; non-GAAP diluted EPS was $1.54 versus $1.56.
  • Fiscal 2026 non-GAAP diluted EPS outlook raised to $2.85 or better from $2.70 or better.
  • Agreed to acquire 80% of TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments; closing is expected in the first half of fiscal 2027.
Read the filing on SEC.gov ↗
May 6, 4:16 PM ET

Central Garden & Pet Q2 net sales rise to $906 million, GAAP EPS $1.28 vs. $0.98

Positive earnings Written later 2.02

Central Garden & Pet reported fiscal 2026 second-quarter net sales of $906 million, up from $834 million a year earlier, and GAAP diluted EPS of $1.28, up from $0.98. The company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better and said it entered a pet distribution partnership with Phillips after the quarter, in which Central keeps a 20% stake. The results are preliminary until the company files its Form 10-Q.

  • Net sales $906 million vs. $834 million; operating income $114 million vs. $93 million.
  • GAAP diluted EPS $1.28 vs. $0.98; non-GAAP diluted EPS $1.29 vs. $1.04.
  • Fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better reaffirmed.
  • Central to retain a 20% stake in the new pet distribution business; Phillips and its investors hold 80%.
Read the filing on SEC.gov ↗
Feb 18, 4:05 PM ET

Central Garden & Pet raises buyback authorization by $100 million to about $127 million

Positive shareholder Written later 5.025.078.01

On February 11, 2026, Central Garden & Pet's board approved a $100 million increase in the company's share repurchase authorization, bringing the total to approximately $127 million as of that date. The same day, shareholders elected nine directors, ratified Deloitte & Touche LLP as auditor, and approved the advisory vote on executive pay. The filing also discloses the appointment of Kay M. Schwichtenberg to the board, effective March 1, 2026.

  • Board approved a $100 million increase to the share repurchase authorization on February 11, 2026; total authorization is approximately $127 million as of that date.
  • Company press release states management considers the market price of its shares to be currently undervalued.
  • Kay M. Schwichtenberg appointed to the board effective March 1, 2026, and to the Audit Committee; she retired as Executive Vice President, Animal & Public Health in February 2023.
  • Shareholders approved the executive compensation advisory vote with 16,346,943 votes for and 218,084 against.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Recent SEC filings

EDGAR ↗

Famous investors who own CENTA

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $12.47M0.02% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Trades disclosed by members of Congress

All CENTA congressional trades →
TradedMemberTypeAmount
Mar 03, 2026Gilbert Cisneros CA-31Buy$1,001 – $15,000
Apr 09, 2025Josh Gottheimer NJ-05 · JointSell (partial)$1,001 – $15,000

From House periodic transaction reports (STOCK Act); amounts are the form's ranges.

Prices are end-of-day and split-adjusted. Financial data from Central Garden & Pet Company (Class A)'s SEC XBRL filings. Not investment advice.